tenofovir has been researched along with Herpes Genitalis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 21 (91.30) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbai, NS; Naidoo, S; Nyirenda, M; Ramjee, G | 1 |
| Andrei, G; Gillemot, S; Snoeck, R; Topalis, D | 1 |
| Chirenje, ZM; Deal, C; Hendrix, CW; Hillier, SL; Kelly, C; Marrazzo, JM; Marzinke, MA; Morrow, RA; Piper, J; Rabe, L; Richardson, B; Schwartz, JL | 1 |
| Anderson, SM; Doncel, GF; Gajer, P; Marzinke, MA; Ravel, J; Schwartz, JL; Thurman, AR; Yousefieh, N | 1 |
| Baeten, JM; Celum, C; Irungu, E; Katabira, E; Lingappa, JR; Lund, JM; Meyers, AFA; Mugo, N; Muwonge, TR; Pattacini, L; Plews, M; Richert-Spuhler, LE | 1 |
| Herold, BC; Jandl, T; Kiser, PF; Nagaraja, U; Nixon, B; Taneva, E; Teller, RS; Wang, Y | 1 |
| Cox, AP; Delany-Moretlwe, S; Foss, AM; Heise, L; Mertenskoetter, T; Meyer-Rath, G; Rees, H; Terris-Prestholt, F; Vickerman, P; Watts, CH | 1 |
| Baeten, JM; Celum, C; Donnell, D; Fife, KH; Hendrix, CW; Hong, T; Morrow, RA; Mujugira, A; Nakku-Joloba, E; Thomas, KK | 1 |
| Alt, C; Shankar, GN | 1 |
| Bender Ignacio, RA; Huang, ML; Johnston, C; Magaret, AS; Marrazzo, J; Perti, T; Rajagopal, S; Selke, S; Stevens, CE; Wald, A | 1 |
| Abdool Karim, Q; Abdool Karim, SS; Baxter, C; Gengiah, TN; Grobler, AC; Kashuba, A; Kharsany, AB; Mansoor, LE; Mindel, A; Samsunder, N; Werner, L | 1 |
| Cheshenko, N; Crooker, K; Frank, B; Herold, BC; Kiser, PF; Mesquita, PM; Ott, A; Park, SH; Su, JT; Szleifer, I; Taneva, E | 1 |
| Brand, RM; Carballo-Diéguez, A; Cranston, RD; Dolezal, C; Duffill, K; Engstrom, JC; Febo, I; Frasca, T; Giguere, R; Jacobson, C; Leu, CS; Mayer, KH; McGowan, I; Nikiforov, A; Park, SY; Schwartz, JL; Siegel, A | 1 |
| Cheshenko, N; Fakioglu, E; Herold, BC; Keller, MJ; Mesquita, PM; Wilson, SS | 1 |
| Andrei, G; Balestra, E; Balzarini, J; Cihlar, T; Introini, A; Lisco, A; Margolis, L; Perno, CF; Snoeck, R; van den Oord, J; Vanpouille, C | 1 |
| Baum, MM; Butkyavichene, I; Clark, MR; Friend, DR; Gilman, J; Kennedy, S; Kopin, E; Malone, AM; Moss, JA; Motamedi, M; Nguyen, C; Smith, TJ; Vincent, KL | 1 |
| Friend, DR | 1 |
| Herold, BC; Huber, AM; Kiser, PF; Mesquita, PM; Rastogi, R; Segarra, TJ; Teller, RS; Torres, NM | 1 |
| Abdool Karim, Q; Abdool Karim, SS; Altfeld, M; Carr, WH; Naranbhai, V; Ndung'u, T | 1 |
| Abdool Karim, Q; Abdool Karim, SS; Altfeld, M; Carr, WH; Durgiah, R; Naranbhai, V; Samsunder, N; Sibeko, S | 1 |
| Melchjorsen, J; Paludan, SR; Reinert, LS; Søgaard, OS; Tolstrup, M; Vibholm, L; Østergaard, L | 1 |
| Cohen, J | 1 |
1 review(s) available for tenofovir and Herpes Genitalis
| Article | Year |
|---|---|
Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
Topics: Adenine; Administration, Intravaginal; Anti-Infective Agents; Antiviral Agents; Biopharmaceutics; Contraception; Disease Transmission, Infectious; Drug Delivery Systems; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Unplanned; Tenofovir | 2012 |
8 trial(s) available for tenofovir and Herpes Genitalis
| Article | Year |
|---|---|
Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Cross-Sectional Studies; Developing Countries; Double-Blind Method; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Gels; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seronegativity; Humans; Incidence; Risk Factors; South Africa; Tenofovir; Unsafe Sex; Vaginosis, Bacterial; Young Adult | 2018 |
Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial.
Topics: Adolescent; Adult; Antiviral Agents; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Incidence; Pre-Exposure Prophylaxis; Sexual Behavior; Tenofovir; Vaginal Creams, Foams, and Jellies; Young Adult | 2019 |
Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Device Removal; Female; Herpes Genitalis; HIV Infections; Humans; Levonorgestrel; Microbiota; Middle Aged; Mucous Membrane; Organophosphates; Tenofovir; Vagina; Young Adult | 2019 |
Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women.
Topics: Adult; Female; Genitalia, Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Humans; Immunity, Mucosal; Mucous Membrane; Pre-Exposure Prophylaxis; T-Lymphocytes; Tenofovir; Virus Shedding | 2019 |
Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.
Topics: Adenine; Administration, Oral; Adult; Anti-Retroviral Agents; Antiviral Agents; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Herpes Genitalis; Herpesvirus 2, Human; Heterosexuality; HIV Infections; HIV Seronegativity; HIV-1; Humans; Incidence; Male; Medication Adherence; Organophosphonates; RNA, Viral; Tenofovir | 2014 |
Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Antiviral Agents; Cross-Over Studies; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Middle Aged; Placebos; Tenofovir; Treatment Outcome; Virus Shedding | 2015 |
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection.
Topics: Adenine; Administration, Intravaginal; Adult; Double-Blind Method; Female; Follow-Up Studies; Gels; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seronegativity; Humans; Incidence; Kaplan-Meier Estimate; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult | 2015 |
Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women.
Topics: Administration, Rectal; Adolescent; Adult; Anti-HIV Agents; Chlamydia Infections; Cross-Sectional Studies; Female; Gels; Herpes Genitalis; HIV Infections; Homosexuality, Male; Humans; Male; Sexually Transmitted Diseases; Tenofovir; Transgender Persons; Young Adult | 2016 |
14 other study(ies) available for tenofovir and Herpes Genitalis
| Article | Year |
|---|---|
The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Cells, Cultured; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Mutation, Missense; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Selection, Genetic; Sequence Analysis, DNA; Tenofovir; Viral Proteins | 2018 |
Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.
Topics: Adenine; Administration, Intravaginal; Animals; Antiviral Agents; Contraceptive Devices, Female; Disease Models, Animal; Drug Administration Schedule; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Mice; Mice, Inbred BALB C; Organophosphonates; Survival Analysis; Tenofovir; Vagina; Vaginal Creams, Foams, and Jellies | 2014 |
Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices.
Topics: Adenine; Anti-HIV Agents; Circumcision, Male; Cost-Benefit Analysis; Female; Forecasting; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seropositivity; Humans; Incidence; Male; Models, Economic; Organophosphonates; Prevalence; South Africa; Tenofovir | 2014 |
Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.
Topics: Acrylic Resins; Acyclovir; Adenine; Animals; Anti-Infective Agents; Chlorocebus aethiops; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Female; Herpes Genitalis; Herpesvirus 2, Human; Mice, Inbred BALB C; Organophosphonates; Poloxamer; Rabbits; Rats, Sprague-Dawley; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vero Cells | 2014 |
Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.
Topics: Administration, Intravaginal; Anti-HIV Agents; Biological Transport; Carboxylic Ester Hydrolases; Cell Line; Chromatography, High Pressure Liquid; Endocytosis; Epithelial Cells; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Nitrophenols; Organophosphorus Compounds; T-Lymphocytes; Tandem Mass Spectrometry; Tenofovir | 2015 |
Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
Topics: Adenine; Administration, Intravaginal; Animals; Anti-Infective Agents; Antiviral Agents; Biomarkers; Disease Models, Animal; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Mice; Mice, Inbred BALB C; Naphthalenesulfonates; Nonoxynol; Organophosphonates; Polymers; Predictive Value of Tests; Risk Assessment; Tenofovir | 2009 |
Prevention. Study reveals that vaginal gel reduces HIV, herpes.
Topics: Adenine; Female; Gels; Herpes Genitalis; HIV Infections; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Vagina | 2010 |
Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.
Topics: Adenine; Administration, Topical; Animals; Anti-Infective Agents; Cells, Cultured; DNA-Directed DNA Polymerase; DNA, Viral; Exodeoxyribonucleases; Herpes Genitalis; Herpesvirus 2, Human; HIV Reverse Transcriptase; Humans; Mice; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Sequence Analysis, DNA; Tenofovir; Thymidine Kinase; Viral Proteins | 2011 |
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
Topics: Acyclovir; Adenine; Administration, Intravaginal; Animals; Anti-HIV Agents; Antiviral Agents; Delayed-Action Preparations; Disease Models, Animal; Drug Combinations; Drug Delivery Systems; Equipment Design; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Organophosphonates; Rabbits; Sexually Transmitted Diseases, Viral; Tenofovir; Treatment Outcome | 2012 |
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection.
Topics: Adenine; Antiviral Agents; Cell Culture Techniques; Chemoprevention; Contraceptive Devices, Female; Female; Herpes Genitalis; HIV; HIV Infections; Humans; Organ Culture Techniques; Organophosphonates; Simplexvirus; Tenofovir | 2012 |
Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial.
Topics: Adenine; Administration, Topical; Adult; Anti-HIV Agents; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Proliferation; Clinical Trials as Topic; Disease Susceptibility; Female; Flow Cytometry; Herpes Genitalis; HIV Seropositivity; HIV-1; Humans; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Middle Aged; Organophosphonates; Risk Assessment; Sexual Behavior; South Africa; Tenofovir; Vaginal Creams, Foams, and Jellies | 2012 |
Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.
Topics: Adenine; Adult; Anti-HIV Agents; Avian Proteins; Case-Control Studies; Coinfection; Cytokines; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Humans; Immunity, Innate; Logistic Models; Lymphocyte Activation; Organophosphonates; Platelet Count; Principal Component Analysis; Randomized Controlled Trials as Topic; Risk Factors; Tenofovir; Vaginal Creams, Foams, and Jellies; Young Adult | 2012 |
Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
Topics: Adenine; Administration, Topical; Animals; Anti-Infective Agents; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Female; Herpes Genitalis; Interferon-gamma; Interleukin-2; Mice; Mice, Inbred C57BL; Organophosphonates; Tenofovir; Tumor Necrosis Factor-alpha; Vagina; Vaginal Creams, Foams, and Jellies; Virus Shedding | 2012 |
HIV/AIDS. Prevention cocktails: combining tools to Stop HIV's spread.
Topics: Acyclovir; Adenine; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Antiviral Agents; Bupropion; Circumcision, Male; Clinical Trials as Topic; Contraceptive Devices, Female; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV; HIV Infections; Humans; Hygiene; Male; Organophosphonates; Sexual Behavior; Tenofovir; Viral Load | 2005 |